Random drug testing to reduce the incidence of addiction in anesthesia residents: Preliminary results from one program

Anesthesia and Analgesia

Volumn 107, Issue 2, 2008, Pages 630-635

  Fitzsimons, Michael G ^a   Baker, Keith H ^a   Lowenstein, Edward ^a   Zapol, Warren M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA; ARTICLE; COST BENEFIT ANALYSIS; DRUG DEPENDENCE; DRUG SCREENING; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; PRIORITY JOURNAL; RESIDENTIAL HOME; SUBSTANCE ABUSE; ANESTHESIOLOGY; CHEMISTRY; EDUCATION; MALPRACTICE; MEDICAL EDUCATION; URINE;

ANESTHESIOLOGY; HUMANS; INTERNSHIP AND RESIDENCY; PHYSICIAN IMPAIRMENT; SUBSTANCE ABUSE DETECTION; URINE;

EID: 49949104433     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318176fefa     Document Type: Article

References (25)

1. Brewster JM. Prevalence of alcohol and other drug problems among physicians. JAMA 1986;255:1913-20
2. Booth JV, Grossman D, Moore J, Lineberger C, Reynolds JD, Reves JG, Sheffield D. Substance abuse among physicians: a survey of academic anesthesiology programs. Anesth Analg 2002;95:1024-30
3. Gold MS, Byasr JA, Frist-Pineda K. Occupational exposure and addictions for physicians: case studies and theoretical implications. Psychiatr Clin North Am 2004;27:745-53
4. McAuliffe PF, Gold MS, Bajpai L, Merves ML, Frost-Pineda K, Pomm RM, Goldberger BA, Melker RJ, Cendan JC. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses 2006;66:874-82
5. Collins GB, McAllister MS, Jenson M, Gooden TA. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Anesth Analg 2005;101:1457-62
6. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000;93:922-30
7. Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia's Impaired Physician's Program. Review of the first 1000 physicians: analysis of specialty. JAMA 1987;257: 2927-30
8. Epstein RH, Gratch DM, Grunwald Z. Development of a scheduled drug diversion surveillance system based on an analysis of atypical drug transactions. Anesth Analg 2007;105:1053-60
9. Bray RM, Marsden ME, Rachal JV, Peterson MR. Drugs in the military workplace: results of the 1988 worldwide survey. In: Gust SW, Walsh JM, Thomas LB, Crouch DJ, eds. Drugs in the workplace research and evaluation data. Vol. II. NIDA Monograph Series No. 100. Washington, DC: NIDA, 1990:25-44
10. Jacobs WS, Repetto M, Vinson S, Pomm R, Gold M. Random urine testing as an intervention for drug addiction. Psychiatric Ann 2004;34:781-4
11. Shore JH. The Oregon experience with impaired physicians on probation. An eight-year follow-up. JAMA 1987;257:2931-4
12. Lewy RM. Pre-employment drug testing of housestaff physicians at a large urban hospital. Acad Med 1991;66:618-9
13. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, Henthorn TK. A survey of propofol abuse in academic anesthesia programs. Anesth Analg 2007;105: 1066-71
14. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Hopkins K, Rowland M. Disposition in male volunteers of a subanesthetic does of an oil in emulsion of 14C-propofol. Xenobiotica 1988;18: 429-40
15. Sgan SL, Hanzlick R. The medical review officer. A potential role for the medical examiner. Am J Forensic Med Pathol 2003;24: 346-50
16. Gravenstein JS, Kory WP, Marks RG. Drug abuse by anesthesia personnel. Anesth Analg 1983;62:467-72
17. Peat MA. Financial viability of screening for drugs of abuse. Clin Chem 1995;41:805-8
18. Zwerling C, Ryan J, Orlav EJ. Costs and benefits of preemployment drug screening. JAMA 1992;267:91-3
19. Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 2004;26:200-5
20. Zacher JL, Givone DM. False-positive urine opiate screening associated with fludroquinolone use. Ann Pharmacother 2004;38:1525-8
21. Daher R, Haidar JH, Al-Amin H. Rifampin interference with opiate immunoassays. Clin Chem 2002;48:203-4
22. Fraser AD, Howell P. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine. J Anal Toxicol 1998;22:50-4
23. Rollins DE, Jennison TA, Jones G. Investigation of interference by nonsteroidal anti-inflammatory drugs in urine tests for abused drugs. Clin Chem 1990;36:602-6
24. Struempler RE. Excretion of codeine and morphine following ingestion of poppy seeds. J Anal Toxicol 1987;11:97-9
25. Leape LL, Fromson JA. Problem doctors: is there is system-level solution. Ann Intern Med 2006;144:107-15